Chase Investment Counsel Corp Innoviva, Inc. Call Options Transaction History
Chase Investment Counsel Corp
- $262 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INVA
# of Institutions
221Shares Held
79MCall Options Held
45.9KPut Options Held
14.1K-
Black Rock Inc. New York, NY10.1MShares$174 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$125 Million19.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.29MShares$108 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.27MShares$108 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$108 Million0.14% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.2B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...